The Quanterix SR-X Ultra-Sensitive Biomarker Detection System is the latest instrument powered by Simoa® technology offering researchers access to ultra-sensitive biomarker detection capabilities in a compact affordable system. Join us to learn more!
The Quanterix SR-X Ultra-Sensitive Biomarker Detection System is the latest instrument powered by Simoa® technology offering researchers access to ultra-sensitive biomarker detection capabilities in a compact affordable system. Join us to learn more!
The Quanterix SR-X Ultra-Sensitive Biomarker Detection System is the latest instrument powered by Simoa® technology offering researchers access to ultra-sensitive biomarker detection capabilities in a compact affordable system. Join us to learn more!
In this seminar, we will discuss the particularly striking results from our recent study of NfL in Huntington's disease and why we think it has real potential to change the course of therapeutic development in HD and other neurogenerative diseases.
AGENDA:
Join us to learn more about the Simoa HD-1 Analyzer, an ultra-sensitive fully automated immunoassay platform capable of delivering LODs at the femtogram level, multiplexing and of measuring individual proteins at concentrations 1,000 times lower than existing te
Join our CEO Kevin Hrusovsky, Dr. Jessica Gill (NIH) and Dr. Henrik Zetterberg (University of Gothenburg) as they discuss how Simoa Technology uses ultrasensitive biomarker assays to enable precision health with case studies in neurodegeneration and neurotrauma.
